1. "Suresh Jhanwar"
Formats
  1. Journal Article (191)
  2. Meeting Abstract (99)
  3. Book Section (2)
  4. Review (1)
Groups
  1. Department of Medicine (125)
  2. GSK Faculty (101)
  3. Sloan Kettering Institute Faculty (77)
  4. Tow Center for Developmental Oncology (TCDO) (77)
  5. Hematologic Malignancies, Division of (66)
  6. Human Oncology and Pathogenesis Program (58)

More Groups

People
  1. Suresh Jhanwar (293)
  2. Raju Chaganti (52)
  3. Marc Ladanyi (50)
  4. Kenneth Offit (35)
  5. Daniel Filippa (20)
  6. Stephen Nimer (18)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (1)
  4. 2017 (3)
  5. 2016 (1)
  6. 2015 (3)

More Years

Publications
  1. Blood (40)
  2. Cancer Research (21)
  3. Laboratory Investigation (16)
  4. Genes Chromosomes and Cancer (15)
  5. Journal of Clinical Oncology (11)
  6. Oncogene (11)

More Publications

Publishers
  1. American Association for Cancer Research (41)
  2. American Society of Hematology (40)
  3. Nature Publishing Group (34)
  4. Elsevier Inc. (20)
  5. Elsevier Science, Inc. (20)
  6. Wiley Periodicals, Inc (16)

More Publishers

Results (293)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-related cancers: A brief review of current status and future prospects
    Review

    Elahi, A. H.; Morales, C. S.; Xu, X. L.; Eliades, A.; Patsalis, P. C.; Abramson, D. H.; Jhanwar, S. C.
    Advances in Biological Regulation (2023)

    Fulltext@MSK | Save
  • Somatic epigenetic silencing of RIPK3 inactivates necroptosis and contributes to chemoresistance in malignant mesothelioma
    Journal Article

    Tan, Y.; Sementino, E.; Cheung, M.; Peri, S.; Menges, C. W.; Kukuyan, A. M.; Zhang, T.; Khazak, V.; Fox, L. A.; Ross, E. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Cancer genomics of lung cancer including malignant mesothelioma: A brief overview of current status and future prospects
    Journal Article

    Jhanwar, S. C.; Xu, X. L.; Elahi, A. H.; Abramson, D. H.
    Advances in Biological Regulation (2020)

    Fulltext@MSK | Save
  • SKP2 activation by thyroid hormone receptor β2 bypasses Rb-dependent proliferation in Rb-deficient cells
    Journal Article

    Xu, X. L.; Li, Z.; Liu, A.; Fan, X.; Hu, D. N.; Qi, D. L.; Chitty, D. W.; Jia, R.; Qui, J.; Wang, J. Q.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Genomic instability and proliferation/survival pathways in RB1-deficient malignancies
    Journal Article

    Pappas, L.; Xu, X. L.; Abramson, D. H.; Jhanwar, S. C.
    Advances in Biological Regulation (2017)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
    Journal Article

    Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Stem cell transplantation in adults with acute myelogenous leukemia, normal cytogenetics, and the FLT3-ITD mutation
    Journal Article

    Berman, E.; Maloy, M.; Devlin, S.; Jhanwar, S.; Papadopoulos, E.; Jakubowski, A.
    Leukemia Research (2016)

    Fulltext@MSK | Save
  • NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition
    Journal Article

    Garcia-Rendueles, M. E. R.; Ricarte-Filho, J. C.; Untch, B. R.; Landa, I.; Knauf, J. A.; Voza, F.; Smith, V. E.; Ganly, I.; Taylor, B. S.; Persaud, Y.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview
    Journal Article

    Jhanwar, S. C.
    Advances in Biological Regulation (2015)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma patients treated with novel agent based induction regimens even after autologous transplantation
    Meeting Abstract

    Shah, G. L.; Landry, C.; Londono, D.; Devlin, S.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save